Taken together, our data demonstrated that targeting DNA‐PKcs with the small‐molecule inhibitor NU7441 synergizes with TMZ to reduce Ep‐GBM tumorigenicity and prolong animal survival. The gene discussed is PRKDC; the disease is glioblastoma.